A novel approach to control diabetes is based on incretin hormone glucagon-like peptide 1 (GLP-1), which normalizes blood glucose levels and reduces postprandial glycemia by stimulating insulin secretion [18]. This evidence concerns the gene GCG and diabetes mellitus.